Selective Role of the Catalytic PI3K Subunit p110β in Impaired Higher Order Cognition in Fragile X Syndrome  by Gross, Christina et al.
Cell Reports
ReportSelective Role of the Catalytic PI3K
Subunit p110b in Impaired Higher Order
Cognition in Fragile X Syndrome
Christina Gross,1,5,* Nisha Raj,1 Gemma Molinaro,4 Amanda G. Allen,2,3 Alonzo J. Whyte,1,2,3 Jay R. Gibson,4
Kimberly M. Huber,4 Shannon L. Gourley,2,3 and Gary J. Bassell1,*
1Department of Cell Biology
2Department of Pediatrics
Emory University School of Medicine, Atlanta, GA 30322, USA
3Yerkes National Primate Research Center, Emory University, Atlanta, GA 30322, USA
4Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
5Present address: Division of Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA
*Correspondence: christina.gross@cchmc.org (C.G.), gbassel@emory.edu (G.J.B.)
http://dx.doi.org/10.1016/j.celrep.2015.03.065
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
Distinct isoforms of the PI3K catalytic subunit have
specialized functions in the brain, but their role in
cognition is unknown. Here, we show that the cata-
lytic subunit p110b plays an important role in pre-
frontal cortex (PFC)-dependent cognitive defects in
mouse models of Fragile X syndrome (FXS), an in-
herited intellectual disability. FXS is caused by loss
of function of the fragile X mental retardation protein
(FMRP), which binds and translationally represses
mRNAs. PFC-selective knockdown of p110b, an
FMRP target that is translationally upregulated in
FXS, reverses deficits in higher cognition in Fmr1
knockout mice. Genetic full-body reduction of
p110b in Fmr1 knockout mice normalizes excessive
PI3K activity, restores stimulus-induced protein
synthesis, and corrects increased dendritic spine
density and behavior. Notably, adult-onset PFC-
selective Fmr1 knockdown mice show impaired
cognition, which is rescued by simultaneous p110b
knockdown. Our results suggest that FMRP-medi-
ated control of p110b is crucial for neuronal protein
synthesis and cognition.INTRODUCTION
Fragile X syndrome (FXS), an inherited form of intellectual
disability, is caused by loss of function of the fragile X mental
retardation protein (FMRP). FMRP is an mRNA-binding protein
that associates with numerous mRNAs and often represses
translation (Bhakar et al., 2012). Consequently, loss of FMRP
leads to excessive and dysregulated translation of many
mRNAs, which may underlie the behavioral and cognitive de-
fects in humans with FXS.Group1metabotropic glutamate receptor (mGlu1/5)-mediated
signaling and protein synthesis are increased and stimulus-
insensitive in animal models of FXS, yet the underlyingmolecular
mechanisms are unclear. The mGluR theory of FXS posits that
antagonism of mGlu1/5 receptors is an effective treatment for
FXS (Bear et al., 2004). Several preclinical studies provided
substantial support for the mGluR theory; however, recent
phase 3 clinical trials with mGlu5-negative modulators have not
shown the expected improvements in adolescents or adults
withFXS.These results suggest that further analysisof themolec-
ular mechanisms underlying dysregulated mGlu1/5-dependent
neuronal function in the absence of FMRP is needed to develop
efficient therapies for humans with FXS. FMRP targets that regu-
late signaling downstream of mGlu1/5 may provide alternative
treatment strategies.
The phosphoinositide-3 kinase (PI3K) complex is an important
mediator of mGlu1/5-dependent signaling. Recent work has
shown that FMRP directly controls mRNA translation and protein
expression of several components of the PI3K complex, sug-
gesting that FMRP may be a central regulator of PI3K signaling
(Ascano et al., 2012; Darnell et al., 2011; Gross et al., 2010;
Sharma et al., 2010). One of those, Pik3cb mRNA, which en-
codes the PI3K catalytic subunit p110b, has been confirmed
as FMRP-associated mRNA in three independent studies
(Ascano et al., 2012; Gross et al., 2010; Miyashiro et al., 2003).
Increased expression of p110b protein was observed in the
brains of Fmr1 knockout (Fmr1KO) mice (Gross et al., 2010;
Sharma et al., 2010) and in FXS patient cells (Gross and Bassell,
2012; Kumari et al., 2014). Here, we employed genetic rescue
strategies in FXS mouse models to test the hypothesis that
increased p110b protein contributes to FXS-associated molecu-
lar, behavioral, and cognitive defects and thusmay be a potential
therapeutic target.
To directly assess the role of FMRP-mediated regulation of
p110b in the prefrontal cortex (PFC), which is known to be
involved in higher order cognitive function particularly affected
in humanswith FXS, we developed two approaches for the study
of FXS that involved PFC-selective gene knockdown in postnatalCell Reports 11, 681–688, May 5, 2015 ª2015 The Authors 681
mice. In one approach, Pik3cb was PFC-selectively reduced in
adult Fmr1WT and Fmr1KO mice. In a second approach, the
effects of adult-onset Fmr1 silencing in the PFC with or without
simultaneous p110b knockdown were assessed. In addition,
we genetically reduced p110b in Fmr1KO mice using Pik3cb het-
erozygous mice. Collectively, these studies show that reducing
p110b in FXS mouse models decreases excessive mGlu1/5-
dependent PI3K signaling and restores protein synthesis-depen-
dent neuronal function on molecular, cellular, behavioral, and
cognitive levels. In particular, our study reveals adult-onset and
PFC-specific functions of FMRP in behavioral flexibility and de-
cision making and suggests a crucial role of elevated p110b in
mediating these defects in higher cognition.
RESULTS
Selective Reduction of p110b in the PFC Rescues
Impaired Goal-Directed Decision Making in FXS Mouse
Models
Humans with FXS are impaired in higher cognition, including
working memory, behavioral flexibility, and inhibitory control.
The brain region essential for these cognitive functions in hu-
mans and mice is the PFC (Dalley et al., 2004), but the roles of
mRNA targets of FMRP in PFC-dependent higher cognition are
unknown. To analyze the impact of increased translation of the
PI3K catalytic subunit and FMRP target p110b mRNA on PFC-
dependent cognition in the absence of FMRP, we tested deci-
sion-making strategies in mice trained to nose poke for food
reinforcement (see Supplemental Experimental Procedures
and Supplemental Discussion for details).
We first assessed whether Fmr1KO mice showed behavioral
inflexibility in a response-outcome contingency degradation
task. Fmr1KOmice learned to nose poke for food reinforcers (Fig-
ure S1A) and could initially discriminate between reinforced and
nonreinforced responses (Figure S1B). However, when the loca-
tion of the reinforced nose poke was reversed, increasing the
cognitive load of the task, Fmr1KO mice were impaired and re-
sponded indiscriminately (Figure 1A). To test the role of
increased p110b in the PFC of Fmr1KO mice in impaired decision
making, we knocked down Pik3cb, the mRNA coding for p110b,
selectively in the PFC of adult Fmr1KO and WT mice using viral-
expressed Pik3cb-specific shRNA. Western blot analyses of
tissue punches confirmed reduction of p110b protein in the
PFC (Figure S1C), and analysis of co-expressed GFP showed
that the viral infection was restricted to the lateral and medial
prefrontal cortices (Figure S1D). This approach fully rescued de-
cision-making strategies in Fmr1KO mice, but did not affect WT
mice (Figure 1A). In an extinction test, when food reinforcement
was withheld entirely, Fmr1KO mice were also significantly
impaired, and again, PFC-selective Pik3cb knockdown fully
rescued cognitive defects without affectingWTmice (Figure 1B).
Impaired nesting behavior in Fmr1KO mice, which does not
depend on PFC function, but involves the striatum (Afonso
et al., 2007), was not rescued by PFC-selective Pik3cb knock-
down (Figure 1C).
To assess how FMRP expression in the PFC of adult mice
affects cognition, we delivered a lentivirus expressing Fmr1-spe-
cific shRNA selectively in the PFC of adult WT mice to generate682 Cell Reports 11, 681–688, May 5, 2015 ª2015 The Authorslocal Fmr1 knockdown (Fmr1KD) (Figure S1E). Adult-onset PFC-
selective Fmr1KD mice were impaired in behavioral flexibility and
inhibitory control (Figures 1D, 1E, S1F, and S1G), similarly as
observed in full-body Fmr1KO mice. These cognitive defects
were rescued by simultaneous PFC-selective Pik3cb knock-
down using a cocktail of viral-expressed Fmr1- and Pik3cb-
specific shRNAs (Figures 1D, 1E, and S1H). Western blot
quantification of PFC tissue punches showed that Fmr1
knockdown increased, whereas Pik3cb knockdown decreased
phosphorylation of mTOR, a downstream target of PI3K (Figures
1F and S1I).
Genetic Full-Body Reduction of Pik3cb Improves Nest
Building and Reduces Anxiety-Related Behavior in
Fmr1KO Mice
We next analyzed whether increased p110b protein levels in
Fmr1KO mice also play a role in PFC-independent behavioral im-
pairments.We generated full-body Pik3cb heterozygous Fmr1KO
mice by breeding female Fmr1 heterozygous mice with male
mice heterozygous forPik3cb (Bi et al., 2002) (Figure S2A). West-
ern blot analyses confirmed that heterozygosity for Pik3cb
reduced p110b protein expression in Fmr1KO cortex toWT levels
(Figure 2A).
In contrast to the PFC-selective knockdown of p110b, full-
body Pik3cb heterozygosity improved nest building behavior in
both Fmr1KO andWTmice (Figures 2B, 2C, and S2B–S2D; Table
S1). Notably, genetic reduction of p110b normalized excessive
marble burying in Fmr1KO mice to WT levels but, in contrast to
nest building behavior, did not have a significant effect on WT
mice (Figure 2D; Table S1).
Genetic Reduction of p110b Decreases Excessive
mGlu5-Dependent PI3K Activity in Fmr1KO Mice
We hypothesized that alterations in the PI3K subunit composi-
tion associated with the mGlu1/5 complex in the absence of
FMRP may contribute to defective mGlu1/5-mediated neuronal
function. In contrast, other PI3K-associated receptor com-
plexes, such as insulin receptor substrate 2 (IRS-2) complexes,
may be unaffected. Using western blot analyses of mGlu5-spe-
cific immunoprecipitations, we showed increased p110b asso-
ciation with mGlu5 in Fmr1KO cortex compared with WT using
two different antibodies (Figures 3A and 3B, quantified in Fig-
ures S3A and S3B). Moreover, mGlu5 antibodies co-precipi-
tated p110a subunits in Fmr1KO, but not WT cortex, suggesting
aberrant mGlu5 receptor complex composition in the absence
of FMRP (Figure 3A). In contrast, IRS2-associated PI3K
composition was normal, and we detected predominantly
p110a, but virtually no p110b subunits in IRS-2-specific immu-
noprecipitations from both WT and Fmr1KO cortex (Figure 3A,
quantified in Figure S3C). PI3K catalytic subunits associate
with mGlu1/5 via heterotrimeric G proteins (Gbg) (Guillermet-
Guibert et al., 2008) and the PI3K enhancer PIKE-L (Rong
et al., 2003), which is an mRNA target of FMRP (Darnell
et al., 2011; Gross et al., 2010). Our western blot analyses
showed increased association of Gb with mGlu5 receptors in
Fmr1KO cortex, but no changes in PIKE-L association or Gb
total levels (Figure 3C, quantified in Figures S3D–S3F), suggest-
ing that elevated association of PI3K catalytic subunits with
Figure 1. PFC-Selective Reduction of p110b
Restores Goal-Directed Decision Making
and Behavioral Flexibility in Fmr1KO and
PFC-Selective Fmr1 Knockdown Mice
(A) Fmr1KO mice were unable to differentiate be-
tween rewarded and nonrewarded actions after
extended training and reversal of the response-
outcome contingencies, although they were
initially able to acquire the task (see Figures S1A
and S1B). This deficiency was rescued by PFC-
selective Pik3cb knockdown (three-way ANOVA,
p(Fmr1 3 Pik3cb 3 aperture interaction) = 0.023,
F(1,30) = 5.7; post hoc comparisons p < 0.05 in all
groups except for the Fmr1KO mice). Also, see
Figure S1C showing reduction of p110b protein in
PFC tissue punches following lentiviral shRNA
knockdown and Figure S1D showing restriction of
virus expression to the PFC.
(B) Mice were trained to press a lever for a
food reinforcer, leading to similar response rates in
all four groups. When the food was withheld,
Fmr1KO mice showed delayed extinction, which
was reversed by concurrent PFC-selective
Pik3cb knockdown (three-way ANOVA, p(Fmr1 3
Pik3cb 3 session interaction) = 0.03, F(1,27) = 5,
*p < 0.05).
(C) Impaired nesting behavior in Fmr1KO mice was
not rescued by PFC-selective Pik3cb knockdown
(two-way ANOVA, p(Fmr1) = 0.001, F(1,29) = 12.7; p(Pik3cb) = 0.32, F(1,29) = 1.0; p(interaction) = 0.206, F(1,29) = 1.7).
(D) Mice with PFC-selective knockdown of Fmr1 were unable to differentiate between trained actions that were or were not rewarded after reversal of action-
outcome relationship, although they were initially able to acquire the task (see Figures S1F and S1G). This deficiency was rescued by simultaneous Pik3cb
knockdown (two-way ANOVA, p(Fmr1 x Pik3cb interaction) = 0.04, F(1,39) = 4.2). Post hoc comparisons represent p < 0.05 in all groups except for the PFC-
Fmr1KDmice. Also, see Figure S1E showing reduction of FMRP protein in PFC tissue punches following lentiviral shRNA knockdown and Figure S1H showing co-
expression of two viruses in the PFC.
(E) PFC-Fmr1KD mice also show greatly impaired response inhibition during extinction training, which is fully rescued by simultaneous PFC-selective Pik3cb
knockdown (three-way ANOVA, p(Fmr1 3 Pik3cb 3 session interaction) = 0.05, F(1,39) = 4.1; Fmr1KD mice differed significantly from all other mice on day 1 of
training (all p < 0.001)). As in Fmr1KOmice, Fmr1KD response rates ultimately did not differ from control mice with extended training (p = 0.19, final training session
of day 2). Mice with both Fmr1 and Pik3cb KD showed greater inhibitory control than mice with Fmr1 KD alone across all sessions (p < 0.05).
(F) Western blot analyses of PFC tissue punches shows that knockdown of Fmr1 leads to increasedmTORphosphorylation and is reduced byPik3cb knockdown
(n(Fmr1scr/Pik3cbscr) = 4, n(Fmr1KD/Pik3cbscr) = 5, n(Fmr1KD/Pik3cbscr) = 4, n(Fmr1KD/Pik3cbKD) = 8; two-way ANOVA, significant effect of Fmr1 and Pik3cb:
p(Fmr1) = 0.034, F(1, 17) = 5.3; p(Pik3cb) = 0.008, F(1,17) = 9.2; p(interaction) = 0.16, F(1,17) = 2.1; Tukey’s post hoc analyses p(Fmr1KD/Pik3cbscr- Fmr1KD/
Pik3cbKD) = 0.01). As illustrated by the scatter blot, effects of the knockdown were variable. Additional example western blots are shown in Figure S1I.
Error bars represent SEM in (A)–(E) and SD in (F).mGlu5 is mediated at least partially via increased levels of Gb in
mGlu5 complexes.
We next investigated whether reducing p110b normalized
excessive mGlu5-dependent PI3K activity in Fmr1KO mice.
Pik3cb heterozygosity reduced the excess p110b-associated
PI3K activity in Fmr1KO cortical synaptic fractions to WT levels
(Figure 3D) and also reduced increased mGlu5-associated
PI3K activity in Fmr1KO cortical lysates (Figure 3E). In contrast,
and in line with the western blot analyses, IRS-2-associated
PI3K activity, which is mediated by p110a subunits, was unaf-
fected by Pik3cb or Fmr1 genotype (Figure 3F). Pik3cb heterozy-
gosity also reduced the elevated ratios of the PI3K product
phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) and the PI3K
substrate phosphatidylinositol-(4,5)-bisphosphate (PIP2) in hip-
pocampal acidophilic lipid fractions from Fmr1KO mice, suggest-
ing that overall increased PI3K activity in Fmr1KO is reduced to
WT levels by genetic reduction of Pik3cb (Figure 3G). None of
these signalingmechanismswere significantly different inPik3cb
heterozygous mice compared with WT mice (Table S1).Genetic Reduction ofPik3cbRestoresmGlu1/5-Induced
Protein Synthesis and Reduces Increased Dendritic
Spine Density in Fmr1KO Mice
Absence of FMRP in the mouse model and in patient cells leads
to increased and stimulus-insensitive protein synthesis (Gross
et al., 2010; Gross and Bassell, 2012; Kumari et al., 2014; Oster-
weil et al., 2010; Weiler et al., 2004), which is believed to
contribute to neuronal dysfunction and impaired cognition in
FXS. Here, we show that genetically reducing p110b decreases
elevated basal protein synthesis rates (Figure 4A) and restores
mGlu1/5-mediated stimulation of protein synthesis rates in
Fmr1KO cortical synaptic fractions (Figure 4B). In WT mice,
Pik3cb heterozygosity did not have a significant effect on basal
protein synthesis rates, but almost entirely abolished mGlu1/5-
induced stimulation of protein synthesis. Genetic reduction of
Pik3cb also normalized the elevated dendritic spine density in
the hippocampal CA1 area typical for the FXS phenotype to
WT levels, whereas no significant effect on WT mice was de-
tected (Figures 4C, 4D, and S4; Table S1).Cell Reports 11, 681–688, May 5, 2015 ª2015 The Authors 683
Figure 2. Genetic Full-Body Reduction of
p110b Improves Impaired Nest Building
and Rescues Excessive Marble Burying in
Fmr1KO Mice
(A) Pik3cb heterozygosity reduces p110b protein
levels in both Fmr1WT and Fmr1KO background
(two-way ANOVA, p(Fmr1) = 0.093; (F(1,36) = 3.0;
p(Pik3cb) = 0.005, F(1,36) = 9.0; p(interaction) =
0.437, F(1,36) = 0.62). Representative western
blots are shown at the left. Protein levels were
normalized to b-actin. Also see Figure S2A for
breeding scheme.
(B and C) Impaired nesting behavior is improved in Fmr1WT and Fmr1KO mice by genetic reduction of p110b. Nest score (B, two-way ANOVA, p(Fmr1) < 0.001,
F(1, 31) = 37.4; p(Pik3cb) < 0.001, F(1,31) = 19.9; p(interaction) = 0.128, F(1,31) = 2.4) and the average amount of unused nestlet after 24 hr (C, two-way ANOVA,
p(Fmr1) = 0.001, F(1, 31) = 21.6; p(Pik3cb) < 0.001, F(1,31) = 19.9; p(interaction) = 0.777, F(1,31) = 0.08; p(Fmr1WT/Pik3cbWT- Fmr1WT/Pik3cbHET) = 0.019;
(Fmr1KO/Pik3cbWT- Fmr1KO/Pik3cbHET) = 0.009) are shown. See Figures S2B–S2D for representative pictures of nests and analyses after 72 hr.
(D) Genetic reduction of p110b rescues increased marble burying in Fmr1KO mice. Shown are number of marbles buried more than 50% after 15 min (two-way
ANOVA, p(Fmr1) = 0.048, F(1, 30) = 4.3; p(Pik3cb) = 0.168, F(1,30) = 2.0; p(interaction) = 0.005, F(1,30) = 9.4; *p = 0.007, #p = 0.017).
Error bars represent SEM, and n indicates individual mice from at least five different litters.Pik3cb Heterozygosity Reduces Audiogenic Seizure
Susceptibility, but Does Not Rescue Neocortical
Hyperexcitability in Fmr1KO Mice
Humans with FXS have elevated susceptibility to epilepsy and
FXS animal models show increased neuronal excitability.
Fmr1KO mice display enhanced susceptibility to audiogenic sei-
zures, which is rescued by the mGlu5 inhibitor MPEP and the
mTOR inhibitor rapamycin (Busquets-Garcia et al., 2013; Yan
et al., 2005). Here, we show that genetic reduction of Pik3cb, a
mediator of mGlu1/5-dependent mTOR signaling, reduced
audiogenic seizures in Fmr1KO mice without affecting seizure
susceptibility in WT mice (Figure 4E; Table S1).
Fmr1KO mice display neuronal network hyperexcitability, as
evident by the occurrence of prolonged UP states in Fmr1KO tha-
lamocortical slices (Gibson et al., 2008; Gonc¸alves et al., 2013;
Hays et al., 2011). While prolonged UP states in Fmr1KO slices
are shortened by mGlu5 reduction, they are insensitive to protein
synthesis inhibitors (Hays et al., 2011) and PI3K inhibitors (Gross
et al., 2015 [this issue ofCell Reports]). Pik3cb heterozygosity did
not haveaneffect on increasedUPstateduration inFmr1KOorWT
mice (Figures 4F and 4G), suggesting a selective role of p110b for
protein synthesis-dependentmGlu5-mediated neuronal function.
DISCUSSION
Intellectual disability is a defining characteristic and life-long
challenge of humans with FXS, but so far the molecular defects
that could be pharmacologically targeted to improve cognition
are largely unknown. Our study shows that increased expression
of the PI3K catalytic subunit p110b, a confirmed mRNA target of
FMRP, plays an important role in impaired higher cognition in
FXSmousemodels. We provide evidence for an adult-onset crit-
ical role of FMRP in the PFC of mice to regulate PI3K activity and
mediate higher-order cognitive function, which can be rescued
by simultaneous p110b knockdown. This finding suggests that
FMRP is not only important to establish neuronal function during
development, but also has an acute role in cognition in the adult
animal.
Our study also provides insight into dysregulated mGlu1/5 re-
ceptor-mediated signaling and protein synthesis in FXS mice.684 Cell Reports 11, 681–688, May 5, 2015 ª2015 The AuthorsOur biochemical analyses show increased and ectopic associa-
tion of PI3K catalytic subunits with mGlu5 in the absence of
FMRP, which may underlie increased mGlu5-associated PI3K
signaling and stimulus-insensitive mGlu5-mediated protein syn-
thesis. These results suggest that the mechanism of exagger-
ated mGlu5 signaling may be directly attributed to defects in
the molecular composition of the mGlu5-associated PI3K
signaling complex. Of note, dysregulated p110b-dependent
signaling downstream of mGlu1/5 does not mediate prolonged
UP states, a protein synthesis-independent defect in Fmr1KO
mice. Select FMRP targets may thus contribute to specific sub-
sets of FXS-associated defects.
Impaired PFC-Dependent Cognitive Function in FXS Is
Restored by Reducing PI3K Activity
Here, we show that p110b dysregulation in the adult PFC con-
tributes to the cognitive impairment in FXS mouse models.
Constitutive full-body Fmr1KO, as well as adult-onset silencing
of Fmr1 in the PFC, led to impaired decision making, loss of
inhibitory control, and behavioral inflexibility in mice (Figure 1),
suggesting that FMRP is crucial for higher cognitive function in
both developing and mature neurons. Knockdown of Pik3cb in
the PFC of adult mice fully rescues behavioral and cognitive im-
pairments caused by FMRP-deficiency in both Fmr1KD and
Fmr1KO mice, but does not affect WT mice. These findings moti-
vate future research to test whether pharmacological reduction
of PI3K activity improves cognition in animal models of FXS.
p110b Is an Important Mediator of mGlu1/5-Dependent
Protein Synthesis
Cognitive function, such as learning and memory, requires the
activity-induced synthesis of new proteins (Sutton and Schu-
man, 2006). Altered regulation of protein synthesis in the
absence of FMRP may thus play a pivotal role in cognitive
dysfunction in humans with FXS. Here, we show that genetic
reduction of Pik3cb reduced the excess protein synthesis and
restored mGlu1/5-induced protein synthesis in Fmr1KO mice
(Figures 4A and 4B), suggesting that p110b is a mediator of
FMRP’s function to control activity-induced neuronal protein
synthesis and synaptic plasticity.
Figure 3. Genetic Reduction of p110b Res-
cues Dysregulated mGlu5-Mediated PI3K
Activity in Fmr1KO Cortex
(A and B) Co-immunoprecipitations (IPs) with
mGlu5- or IRS2-specific antibodies show that
association of p110b with mGlu5 is increased in
Fmr1KO cortex, whereas no changes were de-
tected in p110a-association with IRS-2 (A, poly-
clonal rabbit anti-mGlu5 and anti-IRS2 antibodies,
and B, monoclonal mouse anti-mGlu5 antibody;
also see Figures S3A–S3C for quantifications).
Note that p110a was detected in mGlu5-IPs from
Fmr1KO cortex, but hardly detectable inmGlu5-IPs
from Fmr1WT cortex (A).
(C) mGlu5-specific IPs show increased associa-
tion of Gb, but unchanged association of PIKE-L
with mGlu5. Also see Figures S3D and S3E for
quantification and Figure S3F showing unchanged
total levels of Gb in Fmr1KO compared to Fmr1WT
mice.
(D) Increased p110b-associated PI3K activity is
reduced to WT levels in cortical synaptic fractions
from Pik3cb heterozygous Fmr1KO mice. PI3K
enzymatic activity of p110b-immunoprecipitates
was measured by ELISA (two-way ANOVA,
p(Fmr1) = 0.013, F(1,22) = 7.3; p(Pik3cb) = 0.107,
F(1,22) = 2.8; p(interaction) = 0.026, F(1,22) = 5.7;
*p = 0.01, #p = 0.032).
(E and F) mGlu5- but not IRS-2-associated PI3K activity is increased in Fmr1KO cortical lysates. Genetic reduction of Pik3cb significantly reduced mGlu5-
associated PI3K activity in Fmr1KO cortex (E, two-way ANOVA, p(Fmr1) = 0.227, F(1,26) = 1.5; p(Pik3cb) = 0.004, F(1,26) = 10.3; p(interaction) = 0.075, F(1,26) =
3.4). In contrast, no significant change was detected in IRS-2-associated PI3K activity (F, two-way ANOVA, p(Fmr1) = 0.499, F(1,27) = 0.471; p(Pik3cb) = 0.904,
F(1,27) = 0.02; p(interaction) = 0.115, F(1,27) = 2.6).
(G) Elevated PIP3/PIP2 ratios in Fmr1KO hippocampus are significantly decreased by genetic reduction ofPik3cb (two-way ANOVA, p(Fmr1) = 0.073, F(1,33) = 3.4;
p(Pik3cb) = 0.041, F(1,33) = 4.5; p(interaction) = 0.044, F(1,33) = 4.4; *p = 0.036, #p = 0.023).
Error bars represent SEM; n represents individual mice from at least five litters, and n is indicated in each figure.We noticed that for most of the tested molecular, cellular,
and behavioral phenotypes, Pik3cb heterozygosity or knock-
down had no significant effect on WT mice. We speculate
that in WT, reduced levels of p110b can be compensated by
other PI3K catalytic or regulatory subunits. However, nest
building behavior was significantly improved in Pik3cb hetero-
zygous mice compared with WT mice, suggesting that reduced
p110b dosage is beneficial for certain behaviors independently
of Fmr1. Pik3cb heterozygosity almost entirely abolished
mGlu1/5-induced increases in protein synthesis rates in WT
mice, suggesting a crucial role of p110b in the regulation of
protein synthesis downstream of mGlu5. Future work is needed
to systematically assess the effect of p110b dosage on specific
behaviors, which may differ depending on the brain regions
involved.
Selective Roles of p110b in Neuronal Hyperactivity in
Fmr1KO Mice
Pik3cb heterozygosity significantly reduced the susceptibility to
audiogenic seizures in Fmr1KO mice (Figure 4E), but did not
reduce prolonged UP states (Figures 4F and 4G). Notably, audio-
genic seizures in a rat model of ethanol-withdrawal were shown
to be reduced by a protein synthesis inhibitor (Oretti et al., 1996).
In contrast, UP states in mice are insensitive to protein synthesis
inhibitors (Hays et al., 2011). This suggests a role for p110b-regu-
lated protein synthesis in the etiology of audiogenic seizures inFmr1KO mice, whereas other p110b- and protein synthesis-inde-
pendent mechanisms may underlie the prolonged UP states.
FMRP regulates many different mRNA targets, and thus,
increased PI3K signaling is certainly not the only factor contrib-
uting to the FXS phenotype. Nonetheless, our study reveals
that the PI3K catalytic subunit p110b is a crucial component of
the pathological mechanisms underlying FXS, in particular dys-
regulated mGlu1/5-mediated protein synthesis and higher
cognition in the adult brain. Future work is needed to evaluate
whether subunit-selective inhibitors for p110b, which are
currently used in clinical trials to treat cancer, might be repur-
posed as therapy for humans with FXS.
EXPERIMENTAL PROCEDURES
Mice
Mice were generated by crossing female Fmr1HET mice (The Jackson Labora-
tory) with male Pik3cb heterozygous mice (Bi et al., 2002) (kindly provided
by Dr. Robert Nussbaum, NIH) and were genotyped by PCR. The animal pro-
tocol was approved by the Institutional Animal Care and Use Committees of
Emory University, UT Southwestern, and Cincinnati Children’s Hospital
Medical Center (CCHMC), and complied with the Guide for the Care and
Use of Laboratory Animals. For details, see Supplemental Experimental
Procedures.
Antibodies, shRNAs, Drugs, and Reagents
Details about antibodies, shRNAs, drugs, and reagents used in this study can
be found in the Supplemental Experimental Procedures.Cell Reports 11, 681–688, May 5, 2015 ª2015 The Authors 685
Figure 4. Genetic Reduction of p110b Restores Dysregulated
mGlu5-Mediated Protein Synthesis, Normalizes Dendritic Spine
Density, but Does Not Shorten Prolonged UP States in Fmr1KO Mice
(A) Increased basal protein synthesis rates in Fmr1KO cortical synaptic frac-
tions, measured by incorporation of radiolabeled amino acids, were signifi-
cantly reduced by genetic reduction of p110b (two-way ANOVA, p(Fmr1) =
0.004, F(1,33) = 9.5; p(Pik3cb) = 0.005, F(1,33) = 8.8; p(interaction) = 0.257,
F(1,33) = 1.3).
(B) Genetic reduction of p110b restores an increase in protein synthesis rates
upon mGlu1/5 stimulation in Fmr1KO cortical synaptic fractions (50 mM DHPG
for 20 min; 2-way ANOVA, p(Fmr1) = 0.001, F(1,33) = 13.5; p(Pik3cb) = 0.057,
F(1,33) = 3.9; p(interaction) = 0.047, F(1,33) = 4.3; *p = 0.001, #p = 0.003).
N represents individual mice from at least five different litters.
(C and D) Genetic reduction of p110b normalizes the increased dendritic spine
density in CA1 apical dendrites to WT levels (two-way ANOVA, p(Fmr1) =
0.014, F(1, 67) = 6.4; p(Pik3cb) = 0.659, F(1,67) = 0.2; p(interaction) = 0.001,
F(1,67) = 11.2; *p < 0.001, #p = 0.039). Example images are shown on the left,
and quantification of number of dendritic spines per 10 mm is shown on the
right; nindicates number of secondary dendrites analyzed (60- to 100-mm
length each, starting from the primary shaft), three to four mice per genotype,
four to eight neurons per mouse, one to two dendrites per neuron. See Fig-
ure S4 for additional analyses. Scale bar is 3 mm.
(E) Genetic reduction of p110b reduces the increased susceptibility to audio-
genic seizures in Fmr1KO mice (Fisher’s exact tests, *p < 0.001; #p = 0.012).
(F and G) Genetic reduction of p110b does not affect duration of UP states in
acute thalamocortical slices from Fmr1KO mice. Example traces for each ge-
notype are shown in (F) and quantification in (G) (two-way ANOVA, p(Fmr1) <
0.001, F(1, 108) = 39.8; p(Pik3cb) = 0.203, F(1,108) = 1.6; p(interaction) = 0.61,
F(1,108) = 0.26). N indicates number of slices from at least three individual mice
per genotype.
Error bars represent SEM.
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For ELISAs and western blot analyses, IRS-2- and mGlu5-specific protein
complexes were immunoprecipitated from cortical lysates, and p110b-com-
plexes were immunoprecipitated from synaptoneurosome preparations
(Gross et al., 2010), using IRS-2-, mGlu5-, or p110b-selective antibodies.
For details, see Supplemental Experimental Procedures.
PI3K Assays and PIP2/PIP3 Mass ELISAs
PI3K activity was measured with a PI3-Kinase Activity ELISA: Pico (Echelon
Biosciences) according to the manufacturer’s protocol as described previ-
ously (Gross and Bassell, 2012). PIP2 and PIP3 in the hippocampus were
quantified using PI(3,4,5)P3 and PI(4,5)P2 mass ELISA kits (Echelon Biosci-
ences) following the manufacturer’s protocol. For details, see Supplemental
Experimental Procedures.
Metabolic Labeling
Protein synthesis rates were quantified in synaptoneurosomes using 35-S-
methionine metabolic labeling as described in Gross et al. (2010). For details,
see Supplemental Experimental Procedures.
Dendritic Spine Analysis
Brains from mice at postnatal days 58–62 were Golgi stained using the FD
Rapid GolgiStain Kit (FD NeuroTechnologies) as described previously (Bhatta-
charya et al., 2012). Dendritic spines per 10-mm segments on the dendrites
were counted using Fiji Imaging software. Dendrites were between 60 and
120 mm in length.We analyzed three to five brains per genotype, approximately
four to eight neurons per brain, and one to two dendrites per neuron. Also see
Supplemental Experimental Procedures.
Audiogenic Seizures
Mice were tested at postnatal days P18–P20, in groups of two or three mice,
always between 7:20 and 7:40 p.m. as described in (Thomas et al., 2011). For
details, see Supplemental Experimental Procedures.
UP States
UP states were performed as described previously (Hays et al., 2011). For de-
tails, see Supplemental Experimental Procedures.
PFC Tissue Punches
After completion of behavioral assays, mice were euthanized and brains
either incubated in 4% paraformaldehyde overnight, cryo-protected in 30%
sucrose and frozen (for fluorescent imaging), or immediately snap frozen
(for tissue punches). Mounted sections were imaged using a Nikon A1R
GaAsP confocal microscope and Fiji software (NIH). For western blotting
of tissue punches, frozen brains were cut in 1-mm sections using a mouse
brain slicer matrix and razor blades, and the PFC area was dissected
using a tissue biopsy punch (1-mm diameter, resulting in tissue punches
with a volume of 0.8 mm3). Tissue was lysed in PI3K assay lysis buffer
(Gross et al., 2010), and equal amounts of protein were analyzed by western
blotting.
In Vivo Stereotactic Gene Knockdown
Stereotaxic coordinates were located on the leveled skull of anaesthetized
mice using Stoelting digital stereotaxes. Lentiviral vector cocktails were
infused in a volume of 0.5 ml at AP+2.6, DV2.8, ML+1.2 and 0.25 ml at
AP+2.0, DV2.8, ML+0.1. The four infusions required 14 min total; needles
were left in place for 5 additional minutes per site. Mice were sutured and
allowed to recover forR3 weeks.
Nest Building Behavior
Nest building was assessed as described in Deacon (2006). For details, see
Supplemental Experimental Procedures.
Marble Burying
Marble burying was assessed similarly as in (Bhattacharya et al., 2012). Mice
were placed in cages with 20 blue small glass beads arranged in a 53 4 grid on
fresh bedding (approximately 8 cm deep). After 15 min, mice were removed,
andmarbles covered 50% or more were scored as ‘‘buried.’’ Mice were tested
between 12 and 3 p.m. and were tested in nesting behavior prior to marble
burying.
Behavioral Testing of Higher Order Cognition
Behavioral assays for decision making and behavioral flexibility were done as
previously described (Gourley et al., 2013). For further details see Supple-
mental Experimental Procedures.
Western Blot Quantification
Equal amounts of protein were loaded on SDS polyacrylamide gels, and
western blots were quantified densitometrically using ImageJ (NIH). Signals
of the band of interest were normalized to a-tubulin or b-actin as indicated.
In most cases, horseradish-peroxidase-coupled secondary antibodies (GE
Healthcare) and enhanced chemiluminescence were used; data shown in
Figures 2A and S3F were obtained using fluorescent secondary antibodies
(Li-Cor) and Odyssey Imaging System. MGlu5-specific signal appeared as
monomer and dimer on most of the western blots, and the signal intensities
for both bands were quantified and added (Figures S3A, S3B, S3D,
and S3E).
Data Acquisition and Statistical Analyses
Mice were genotyped prior to the experiments and assigned ascending
numbers. All statistics were performed using SigmaStat v.3.1, GraphPad
Prism6, or SPSS. For details, see Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supple-
mental Experimental Procedures, four figures, and one table and can
be found with this article online at http://dx.doi.org/10.1016/j.celrep.2015.
03.065.
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